PROCOVA - is it the right tool for your medicinal development?  

EMA qualified PROCOVA™ (Prognostic Covariate Adjustment);  with this you can increase confidence in clinical results and potentially use smaller sample size for Phase II and III randomised controlled trials for regulatory decision making. 

Is this a game changer for medicinal development? What can it do and can not do? Let us answer some common questions for the medicinal developers.